Retrospective Study of the Etiology and Risk Factors of Systemic Inflammatory Response Syndrome After Systematic Transrectal Ultrasound-Guided Prostate Biopsy

References

• Chang AJ, Autio KA, Roach M 3rd, Scher HI. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014;11(6):308–323. doi:10.1038/nrclinonc.2014.6824840073
   PubMed Web of Science ®Google Scholar
• Center MM, Jemal A, Lortet-Tieulent J. International variation n prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079–1092. doi:10.1016/j.eururo.2012.02.05422424666
   PubMed Web of Science ®Google Scholar
• Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer: a review. JAMA. 2017;317(24):2532–2542. doi:10.1001/jama.2017.724828655021
   PubMed Web of Science ®Google Scholar
• Tabayoyong W, Abouassaly R. Prostate cancer screening and the associated controversy. Surg Clin North Am. 2015;95(5):1023–1039. doi:10.1016/j.suc.2015.05.00126315521
   PubMed Web of Science ®Google Scholar
• Endzeliņš E, Melne V, Kalniņa Z, et al. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review. Mol Cancer. 2016;15(1):41. doi:10.1186/s12943-016-0523-527189160
   PubMed Web of Science ®Google Scholar
• Schoots IG, Roobol MJ, Nieboer D. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol. 2015;68(3):438–450. doi:10.1016/j.eururo.2014.11.03725480312
   PubMed Web of Science ®Google Scholar
• van der Leest M, Cornel E, et al. Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol. 2019;75(4):570–578. doi:10.1016/j.eururo.2018.11.02330477981
   PubMed Web of Science ®Google Scholar
• Walsh PC. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. J Urol. 2003;170(1):314.
   Google Scholar
• Raaijmakers R, Kirkels WJ, Roobol MJ, et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology. 2002;60(5):826–830. doi:10.1016/S0090-4295(02)01958-112429309
   PubMed Web of Science ®Google Scholar
• Cussans A, Somani BK, Basarab A. The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review. BJU Int. 2016;117(5):725–731. doi:10.1111/bju.1340226709240
   PubMed Web of Science ®Google Scholar
• Wu YP, Li XD, Ke ZB, et al. Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy. Infect Drug Resist. 2018;11:1491–1497. doi:10.2147/IDR.S17116230271182
   PubMed Web of Science ®Google Scholar
• Shahait M, Degheili J, El-Merhi F, et al. Incidence of sepsis following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon. Int Braz J Urol. 2016;42(1):60–68. doi:10.1590/S1677-5538.IBJU.2014.060727136468
   PubMed Web of Science ®Google Scholar
• Han M, Chang D, Kim C, et al. Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy. J Urol. 2012;188(6):2404–2409. doi:10.1016/j.juro.2012.07.10723088974
   PubMed Web of Science ®Google Scholar
• Teoh JY, Yuen SK, Tsu JH, et al. Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population? Asian J Androl. 2015;17(5):821–825. doi:10.4103/1008-682X.14494525652619
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhu S, Feng G, et al. Is an initial saturation prostate biopsy scheme better than an extended scheme for detection of prostate cancer? A systematic review and meta-analysis. Eur Urol. 2013;63(6):1031–1039. doi:10.1016/j.eururo.2013.01.03523414775
   PubMed Web of Science ®Google Scholar
• Noreikaite J, Jones P, Fitzpatrick J, et al. Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2018;21(2):153–160. doi:10.1038/s41391-018-0032-229487398
   PubMed Web of Science ®Google Scholar
• Lee SJ. Infection after transrectal ultrasound-guided prostate biopsy. Korean J Urol. 2015;56(5):346–350. doi:10.4111/kju.2015.56.5.34625964834
   PubMedGoogle Scholar
• Williamson DA, Barrett LK, Rogers BA. Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. Clin Infect Dis. 2013;57(2):267–274. doi:10.1093/cid/cit19323532481
   PubMed Web of Science ®Google Scholar
• Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64(6):876–892. doi:10.1016/j.eururo.2013.05.04923787356
   PubMed Web of Science ®Google Scholar
• Toner L, Bolton DM, Lawrentschuk N. Prevention of sepsis prior to prostate biopsy. Investig Clin Urol. 2016;57(2):94–99. doi:10.4111/icu.2016.57.2.94
   Web of Science ®Google Scholar
• Roberts MJ, Bennett HY, Harris PN, et al. Prostate biopsy-related infection: a systematic review of risk factors, prevention strategies, and management approaches. Urology. 2017;104:11–21. doi:10.1016/j.urology.2016.12.01128007492
   PubMed Web of Science ®Google Scholar
• Liss MA, Ehdaie B, Loeb S, et al. An update of the american urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol. 2017;198(2):329–334. doi:10.1016/j.juro.2017.01.10328363690
   PubMed Web of Science ®Google Scholar
• Eruz ED, Yalci A, Ozden E, et al. Risk factors for infection development after transrectal prostate biopsy and the role of resistant bacteria in colonic flora. J Infect Dev Ctries. 2017;11(2):188–191. doi:10.3855/jidc.706728248681
   PubMed Web of Science ®Google Scholar
• Wu X, Yu C, Li T, et al. Obesity was an independent risk factor for febrile infection after prostate biopsy: a 10-year single center study in South China. Medicine. 2018;97(1):e9549. doi:10.1097/MD.000000000000954929505534
   PubMed Web of Science ®Google Scholar
• Park J, Cho SY, Lee SB, Son H, Jeong H. Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea. BJU Int. 2014;114(6):891–895. doi:10.1111/bju.1260024314095
   PubMed Web of Science ®Google Scholar
• Rai GS. Erythrocyte sedimentation rate and disease in the elderly. J Am Geriatr Soc. 1979;27(8):382–383. doi:10.1111/j.1532-5415.1979.tb06063.x458093
   PubMed Web of Science ®Google Scholar
• Menees SB, Powell C, Kurlander J, et al. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol. 2015;110(3):444–454. doi:10.1038/ajg.2015.625732419
   PubMed Web of Science ®Google Scholar
• Mosharafa AA, Torky MH, El Said WM, et al. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Urology. 2011;78(3):511–514. doi:10.1016/j.urology.2011.04.06421782225
   PubMed Web of Science ®Google Scholar
• Carignan A, Roussy JF, Lapointe V, et al. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol. 2012;62(3):453–459. doi:10.1016/j.eururo.2012.04.04422575912
   PubMed Web of Science ®Google Scholar
• Wagenlehner FM, van Oostrum E, Tenke P, et al. Infective complications after prostate biopsy: outcome of the global prevalence study of infections in urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol. 2013;63(3):521–527. doi:10.1016/j.eururo.2012.06.00322704727
   PubMed Web of Science ®Google Scholar
• Kalkanlı A, Gezmiş CT, Özkan A, et al. Comparison of single and prolonged fluoroquinolone prophylaxis and risk factors for infectious complications after transrectal prostate biopsy. Balkan Med J. 2018;35(5):373–377. doi:10.4274/balkanmedj.2018.047729866640
   PubMed Web of Science ®Google Scholar
• AlKhateeb SS, AlShammari NA, AlZughaibi MA, et al. The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones. Saudi Med J. 2016;37(8):860–863. doi:10.15537/smj.2016.8.1580327464862
   PubMed Web of Science ®Google Scholar